Overview

Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Status:
NOT_YET_RECRUITING
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the therapeutic effect and safety of Sorafenib in T1DM patients.
Phase:
PHASE2
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University
Treatments:
Sorafenib